Eradication of Chronic Myelogenous Leukemia By Inactivation of the Polycomb Group Protein EZH2

被引：0
|
作者：
Xie, Huafeng [1 ]
Peng, Cong [2 ]
Qi, Jun [3 ]
Cheloni, Giullia [4 ]
Das, Partha [5 ]
Huang, Jialiang [1 ]
Minh Nguyen
Li, Shaoguang [4 ]
Bradner, James E. [6 ]
Orkin, Stuart H. [6 ]
机构：
[1] Harvard Univ, Sch Med, Dana Farber Canc Inst, Boston Childrens Hosp, Boston, MA 02115 USA
[2] Harvard Univ, Sch Med, Boston Childrens Hosp, Boston, MA USA
[3] Harvard Univ, Sch Med, Dana Farber Canc Inst, Boston, MA 02115 USA
[4] Univ Massachusetts, Sch Med, Worcester, MA USA
[5] Boston Childrens Hosp, Boston, MA USA
[6] Dana Farber Canc Inst, Boston, MA 02115 USA
来源：
BLOOD | 2014年 / 124卷 / 21期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页数：3
相关论文
共 50 条
  • [21] Repression of E-Cadherin by the Polycomb Group Protein EZH2 in Pancreatic Cancer
    Toll, A. D.
    Dasgupta, A.
    Potoczek, M.
    Kleer, C. G.
    Brody, J. R.
    Witkiewicz, A. K.
    MODERN PATHOLOGY, 2010, 23 : 372A - 372A
  • [22] The polycomb group protein EZH2 impairs DNA repair in breast epithelial cells
    Zeidler, Michael G.
    Varambally, Sooryanayana
    Cao, Qi
    Chinnaiyan, Arul M.
    Ferguson, David O.
    Merajver, Sofia D.
    Kleer, Celina G.
    CANCER RESEARCH, 2006, 66 (08)
  • [23] The Polycomb group protein EZH2 impairs DNA repair in breast epithelial cells
    Zeidler, M
    Varambally, S
    Cao, Q
    Chinnaiyan, AM
    Ferguson, DO
    Merajver, SD
    Kleer, CG
    NEOPLASIA, 2005, 7 (11): : 1011 - 1019
  • [24] A new transgenic mouse model for conditional overexpression of the Polycomb Group protein EZH2
    Martijn A. J. Koppens
    Ellen Tanger
    Karim Nacerddine
    Bart Westerman
    Ji-Ying Song
    Maarten van Lohuizen
    Transgenic Research, 2017, 26 : 187 - 196
  • [25] Differentiation of Neural Stem Cells into Oligodendrocytes: Involvement of the Polycomb Group Protein Ezh2
    Sher, Falak
    Rossler, Reinhard
    Brouwer, Nieske
    Balasubramaniyan, Veerakumar
    Boddeke, Erik
    Copray, Sjef
    STEM CELLS, 2008, 26 (11) : 2875 - 2883
  • [26] Structural assembly of Polycomb group protein and Insight of EZH2 in cancer progression: A review
    Gautam, Nisha
    Kaur, Mandeep
    Kaur, Satbir
    JOURNAL OF CANCER RESEARCH AND THERAPEUTICS, 2021, 17 (02) : 311 - 326
  • [27] The Polycomb group protein EZH2 is upregulated in proliferating, cultured human mantle cell lymphoma
    Visser, HPJ
    Gunster, MJ
    Kluin-Nelemans, HC
    Manders, EMM
    Raaphorst, FM
    Meijer, CJLM
    Willemze, R
    Otte, AP
    BRITISH JOURNAL OF HAEMATOLOGY, 2001, 112 (04) : 950 - 958
  • [28] Antihistamine Drug Ebastine Inhibits Cancer Growth by Targeting Polycomb Group Protein EZH2
    Li, Qiaqia
    Liu, Kilia Y.
    Liu, Qipeng
    Wang, Guangyu
    Jiang, Weihua
    Meng, Qingshu
    Yi, Yang
    Yang, Yongyong
    Wang, Rui
    Zhu, Sen
    Li, Chao
    Wu, Longxiang
    Zhao, Dongyu
    Yan, Lin
    Zhang, Lili
    Kim, Jung-Sun
    Zu, Xiongbing
    Kozielski, Anthony J.
    Qian, Wei
    Chang, Jenny C.
    Patnaik, Akash
    Chen, Kaifu
    Cao, Qi
    MOLECULAR CANCER THERAPEUTICS, 2020, 19 (10) : 2023 - 2033
  • [29] The polycomb group protein EZH2 regulates actin polymerization in human prostate cancer cells
    Bryant, R. J.
    Winder, S. J.
    Cross, S. S.
    Hamdy, F. C.
    Cunliffel, V. T.
    PROSTATE, 2008, 68 (03): : 255 - 263
  • [30] Survival of skin cancer tumor initiating cells requires the Ezh2 polycomb group protein
    Adhikary, Gautam
    Grun, Dan
    Kerr, Candace
    Balasubramanian, Sivaprakasam
    Rorke, Ellen
    Xu, Wen
    Eckert, Richard
    CANCER RESEARCH, 2015, 75
12345